These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 24968947)

  • 41. Prognostic significance of S100A4 expression in gallbladder cancer.
    Nakamura T; Ajiki T; Murao S; Kamigaki T; Maeda S; Ku Y; Kuroda Y
    Int J Oncol; 2002 May; 20(5):937-41. PubMed ID: 11956586
    [TBL] [Abstract][Full Text] [Related]  

  • 42. p53 nuclear accumulation is not associated with decreased disease-free survival in patients with node positive transitional cell carcinoma of the bladder.
    Fleshner N; Kapusta L; Ezer D; Herschorn S; Klotz L
    J Urol; 2000 Oct; 164(4):1177-82. PubMed ID: 10992361
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Expressions of nm23, P53 and S100A4 proteins and their relationships with metastasis potential in gastric carcinoma].
    Yu GZ; Wang JJ; Chen Y; Ni CR; Zhu MH
    Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Mar; 9(2):165-9. PubMed ID: 16555162
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The expression of S100A4 in human pancreatic cancer is associated with invasion.
    Tsukamoto N; Egawa S; Akada M; Abe K; Saiki Y; Kaneko N; Yokoyama S; Shima K; Yamamura A; Motoi F; Abe H; Hayashi H; Ishida K; Moriya T; Tabata T; Kondo E; Kanai N; Gu Z; Sunamura M; Unno M; Horii A
    Pancreas; 2013 Aug; 42(6):1027-33. PubMed ID: 23851436
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinicopathologic significance of S100A4 expression in osteosarcoma.
    Cao CM; Yang FX; Wang PL; Yang QX; Sun XR
    Eur Rev Med Pharmacol Sci; 2014; 18(6):833-9. PubMed ID: 24706307
    [TBL] [Abstract][Full Text] [Related]  

  • 46. IGFBP-5 overexpression as a poor prognostic factor in patients with urothelial carcinomas of upper urinary tracts and urinary bladder.
    Liang PI; Wang YH; Wu TF; Wu WR; Liao AC; Shen KH; Hsing CH; Shiue YL; Huang HY; Hsu HP; Chen LT; Lin CY; Tai C; Wu JY; Li CF
    J Clin Pathol; 2013 Jul; 66(7):573-82. PubMed ID: 23539739
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ki-67 MIB1 labelling index and the prognosis of primary TaT1 urothelial cell carcinoma of the bladder.
    Quintero A; Alvarez-Kindelan J; Luque RJ; Gonzalez-Campora R; Requena MJ; Montironi R; Lopez-Beltran A
    J Clin Pathol; 2006 Jan; 59(1):83-8. PubMed ID: 16394286
    [TBL] [Abstract][Full Text] [Related]  

  • 48. PTP4A3 Independently Predicts Metastasis and Survival in Upper Tract Urothelial Carcinoma Treated with Radical Nephroureterectomy.
    Yeh HC; Li CC; Huang CN; Hour TC; Yeh BW; Li WM; Liang PI; Chang LL; Li CF; Wu WJ
    J Urol; 2015 Nov; 194(5):1449-55. PubMed ID: 26070892
    [TBL] [Abstract][Full Text] [Related]  

  • 49. S100A4 (Mts1) gene overexpression is associated with invasion and metastasis of papillary thyroid carcinoma.
    Zou M; Al-Baradie RS; Al-Hindi H; Farid NR; Shi Y
    Br J Cancer; 2005 Nov; 93(11):1277-84. PubMed ID: 16265347
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of histological variants on clinical outcomes of patients with upper urinary tract urothelial carcinoma.
    Rink M; Robinson BD; Green DA; Cha EK; Hansen J; Comploj E; Margulis V; Raman JD; Ng CK; Remzi M; Bensalah K; Kabbani W; Haitel A; Rioux-Leclercq N; Guo CC; Chun FK; Kikuchi E; Kassouf W; Sircar K; Sun M; Sonpavde G; Lotan Y; Pycha A; Karakiewicz PI; Scherr DS; Shariat SF
    J Urol; 2012 Aug; 188(2):398-404. PubMed ID: 22698626
    [TBL] [Abstract][Full Text] [Related]  

  • 51. CD103+ Tumor Infiltrating Lymphocytes Predict a Favorable Prognosis in Urothelial Cell Carcinoma of the Bladder.
    Wang B; Wu S; Zeng H; Liu Z; Dong W; He W; Chen X; Dong X; Zheng L; Lin T; Huang J
    J Urol; 2015 Aug; 194(2):556-62. PubMed ID: 25752441
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Expression and clinical significance of 5hmC in bladder urothelial carcinoma].
    Li J; Xu Y; Zhang Z; Zhang M; Zhang Z; Zhang F; Li Q
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Feb; 32(2):232-5. PubMed ID: 26927384
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Osteopontin overexpression predicts poor prognosis of upper urinary tract urothelial carcinoma.
    Ke HL; Chang LL; Yang SF; Lin HH; Li CC; Wu DC; Wu WJ
    Urol Oncol; 2011; 29(6):703-9. PubMed ID: 20022267
    [TBL] [Abstract][Full Text] [Related]  

  • 54. IMP3 predicts aggressive superficial urothelial carcinoma of the bladder.
    Sitnikova L; Mendese G; Liu Q; Woda BA; Lu D; Dresser K; Mohanty S; Rock KL; Jiang Z
    Clin Cancer Res; 2008 Mar; 14(6):1701-6. PubMed ID: 18347170
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The relationship between the expression of E-cadherin and tumor recurrence and progression in high-grade stage T1 bladder urothelial carcinoma.
    Erdemir F; Ozcan F; Kilicaslan I; Parlaktas BS; Uluocak N; Gokce O
    Int Urol Nephrol; 2007; 39(4):1031-7. PubMed ID: 17340210
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Histological and immunohistochemical markers for progression prediction in transurethrally resected high-grade non-muscle invasive bladder cancer.
    Kim K; Cho YM; Park BH; Lee JL; Ro JY; Go H; Shim JW
    Int J Clin Exp Pathol; 2015; 8(1):743-50. PubMed ID: 25755769
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Does presence of squamous and glandular differentiation in urothelial carcinoma of the bladder at cystectomy portend poor prognosis? An intensive case-control analysis.
    Mitra AP; Bartsch CC; Bartsch G; Miranda G; Skinner EC; Daneshmand S
    Urol Oncol; 2014 Feb; 32(2):117-27. PubMed ID: 23477878
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Decreased DOC-2/DAB2 expression in urothelial carcinoma of the bladder.
    Karam JA; Shariat SF; Huang HY; Pong RC; Ashfaq R; Shapiro E; Lotan Y; Sagalowsky AI; Wu XR; Hsieh JT
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4400-6. PubMed ID: 17671122
    [TBL] [Abstract][Full Text] [Related]  

  • 59. S100A4 expression is an early event of papillary carcinoma of the thyroid.
    Ito Y; Yoshida H; Tomoda C; Uruno T; Miya A; Kobayashi K; Matsuzuka F; Kakudo K; Kuma K; Miyauchi A
    Oncology; 2004; 67(5-6):397-402. PubMed ID: 15713996
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Vascular endothelial growth factor-C (VEGF-C) expression predicts lymph node metastasis of transitional cell carcinoma of the bladder.
    Suzuki K; Morita T; Tokue A
    Int J Urol; 2005 Feb; 12(2):152-8. PubMed ID: 15733109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.